Biblio

Export 181 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is X  [Clear All Filters]
2025
T. Ruan, Ling, Y., Wu, C., Niu, Y., Liu, G., Xu, C., Lv, Z., Yuan, Y., Zhou, X., Wang, Q., and Xu, S., “Abnormal epigenetic modification of lysosome and lipid regulating genes in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251322955, 2025.
T. Ruan, Ling, Y., Wu, C., Niu, Y., Liu, G., Xu, C., Lv, Z., Yuan, Y., Zhou, X., Wang, Q., and Xu, S., “Abnormal epigenetic modification of lysosome and lipid regulating genes in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251322955, 2025.
D. Hu, Chen, M., Li, X., Daley, S., Morin, P., Han, Y., Hemberg, M., Weiner, H. L., and Xia, W., “ApoE ε4-dependent Alteration of CXCR3  CD127 CD4 T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251320123, 2025.
K. Ndukwe, Serrano, P. A., Rockwell, P., Xie, L., and Figueiredo-Pereira, M. E., “Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat model.”, J Alzheimers Dis, p. 13872877251314777, 2025.
P. Grau-Jurado, Mostafaei, S., Xu, H., Mo, M., Petek, B., Kalar, I., Naia, L., Kele, J., Maioli, S., Pereira, J. B., Eriksdotter, M., Chatterjee, S., and Garcia-Ptacek, S., “Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.”, J Alzheimers Dis, p. 13872877241307870, 2025.
Y. Zhai, Lu, K., Yuan, Y., Zhang, Z., Xue, L., Zhao, F., Xu, X., and Wang, H., “Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-κB pathway.”, J Alzheimers Dis, p. 13872877251329439, 2025.
Y. Zhai, Lu, K., Yuan, Y., Zhang, Z., Xue, L., Zhao, F., Xu, X., and Wang, H., “Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-κB pathway.”, J Alzheimers Dis, p. 13872877251329439, 2025.
2024
C. Wu, Ruan, T., Yuan, Y., Xu, C., Du, L., Wang, F., and Xu, S., “Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.”, J Alzheimers Dis, vol. 99, no. 3, pp. 1005-1022, 2024.
C. Wu, Ruan, T., Yuan, Y., Xu, C., Du, L., Wang, F., and Xu, S., “Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.”, J Alzheimers Dis, vol. 99, no. 3, pp. 1005-1022, 2024.
T. Wang, Yan, S., Shan, Y., Xing, Y., Bi, S., Chen, Z., Xi, H., Xue, H., Qi, Z., Tang, Y., and Lu, J., “Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 901-912, 2024.
T. Wang, Yan, S., Shan, Y., Xing, Y., Bi, S., Chen, Z., Xi, H., Xue, H., Qi, Z., Tang, Y., and Lu, J., “Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 901-912, 2024.
T. Wang, Yan, S., Shan, Y., Xing, Y., Bi, S., Chen, Z., Xi, H., Xue, H., Qi, Z., Tang, Y., and Lu, J., “Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 901-912, 2024.
D. Li, Xie, Q., Xie, J., Ni, M., Wang, J., Gao, Y., Wang, Y., and Tang, Q., “Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 261-277, 2024.
D. Li, Xie, Q., Xie, J., Ni, M., Wang, J., Gao, Y., Wang, Y., and Tang, Q., “Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 261-277, 2024.
R. Yan, Wang, W., Yang, W., Huang, M., and Xu, W., “Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 99, no. s2, pp. S299-S315, 2024.
P. Du, Zhang, X., Lian, X., Holscher, C., and Xue, G., “O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1051-1068, 2024.
2023
P. Ding, Gorenflo, M. P., Zhu, X., and Xu, R., “Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.”, J Alzheimers Dis, vol. 92, no. 3, pp. 989-1000, 2023.
Y. Xu, Vasiljevic, E., Deming, Y. K., Jonaitis, E. M., Koscik, R. L., Van Hulle, C. A., Lu, Q., Carboni, M., Kollmorgen, G., Wild, N., Carlsson, C. M., Johnson, S. C., Zetterberg, H., Blennow, K., and Engelman, C. D., “Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1587-1605, 2023.
T. A. Lansdell, Xu, H., Galligan, J. J., and Dorrance, A. M., “Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1361-1375, 2023.
H. Liang, Yin, X., Chen, T., Zhang, Y., Zhang, Q., Lin, J., Yin, H., Tang, J., He, Y., Xia, P., Zhu, Y., Li, H., Mo, Y., Li, Y., Wang, Y., Yang, X., and Hu, Z., “Excessive Sedentary Time Is Associated with Cognitive Decline in Older Patients with Minor Ischemic Stroke.”, J Alzheimers Dis, vol. 96, no. 1, pp. 173-181, 2023.
Y. Xu, Zheng, F., Zhong, Q., and Zhu, Y., “Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1173-1198, 2023.
W. Huang, Xia, Q., Zheng, F., Zhao, X., Ge, F., Xiao, J., Liu, Z., Shen, Y., Ye, K., Wang, D., and Li, Y., “Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S335-S354, 2023.
W. Huang, Xia, Q., Zheng, F., Zhao, X., Ge, F., Xiao, J., Liu, Z., Shen, Y., Ye, K., Wang, D., and Li, Y., “Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S335-S354, 2023.
S. Patel, Wei, J., Shi, Z., Rifkin, A. S., S Zheng, L., Gelfman, E., Duggan, D., Helfand, B. T., Hulick, P. J., and Xu, J., “Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 Carriers.”, J Alzheimers Dis, vol. 94, no. 2, pp. 483-489, 2023.
2022
L. Chen, Shen, Q., Xu, S., Yu, H., Pei, S., Zhang, Y., He, X., Wang, Q. Z., and Li, D., “5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 573-585, 2022.

Pages